Scilex Holding (SCLX) Current Leases (2021 - 2026)
Scilex Holding (SCLX) recorded quarterly Current Leases of $1.7 million in Q1 2026, down 0.58% quarter-over-quarter from $1.7 million in Q4 2025, and up 132.84% on a YoY basis from $740000.0 in Q1 2025.
Scilex Holding (SCLX) Current Leases (2021 - 2026) Analysis & Trends
Scilex Holding's Current Leases history runs 6 years deep, the most recent figure standing at $1.7 million for Q1 2026.
- In Q1 2026, Current Leases rose 132.84% year-over-year to $1.7 million; the TTM figure through Mar 2026 stood at $1.7 million (up 132.84% YoY), while the FY2025 annual figure was $1.7 million, up 142.72% from the prior year.
- Current Leases was $1.7 million for Q1 2026 at Scilex Holding, down from $1.7 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $1.7 million in Q4 2025 to a low of $688000.0 in Q3 2024.
- Historically, Current Leases has averaged $888142.9 across 5 years, with a median of $763500.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Current Leases retreated 12.58% in 2024, then jumped 142.72% in 2025.
- A 5-year view of Current Leases shows it stood at $745000.0 in 2022, then grew by 1.88% to $759000.0 in 2023, then retreated by 5.93% to $714000.0 in 2024, then soared by 142.72% to $1.7 million in 2025, then declined by 0.58% to $1.7 million in 2026.
- The last three Current Leases figures came in at $1.7 million (Q1 2026), $1.7 million (Q4 2025), and $796000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | - |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | - |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | - |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | - |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | - |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | - |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | - |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | - |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | - |
| 10 | Scilex Holding | 48.31 Mn | -101.62 Mn | 4.15 Mn | 1.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 Mn |
| Dec 31, 2025 | 1.73 Mn |
| Sep 30, 2025 | 796,000.00 |
| Jun 30, 2025 | 768,000.00 |
| Mar 31, 2025 | 740,000.00 |
| Dec 31, 2024 | 714,000.00 |
| Sep 30, 2024 | 688,000.00 |
| Jun 30, 2024 | 701,000.00 |
| Mar 31, 2024 | 731,000.00 |
| Dec 31, 2023 | 759,000.00 |
| Sep 30, 2023 | 787,000.00 |
| Jun 30, 2023 | 776,000.00 |
| Mar 31, 2023 | 773,000.00 |
| Dec 31, 2022 | 745,000.00 |
| Dec 31, 2021 | 500,000.00 |